Investment objective

To provide long-term capital growth. The fund invests primarily in a portfolio of equity securities of major companies domiciled in the developed countries outside of North America.

Download fund details    Download fund commentary   

Fund details

Series
Currency
Fund code
MER * (%)
F CAD 35071 0.99%

Portfolio analysis As of Feb 28, 2026

98% 2%
Equity Fixed Income

Asset mix

Equity Sector Allocation
Financials25.8%
Industrials21.2%
Health Care10.6%
Consumer Discretionary9.4%
Materials7.8%
Consumer Staples7.5%
Utilities5.5%
Energy4.3%
Information Technology3.2%
Real Estate2.8%
Communication Services1.8%
Top 10 Holdings
% Assets
ASML Holding NV 3.2%
Roche Holding AG 3.2%
Sumitomo Electric Industries Ltd 2.8%
AstraZeneca PLC 2.8%
Mitsubishi Corp 2.7%
Obayashi Corp 2.4%
Iberdrola SA 2.4%
Mitsubishi Estate Co Ltd 2.2%
Mitsubishi Heavy Industries Ltd 2.1%
Unilever PLC 2.1%
Total % of Top 10 Holdings 25.9%

Geographic allocation

Region

Performance analysis

Growth of $10,000 since inception

Calendar returns

Trailing return

1 Mth 3 Mth 6 Mth 1 year 3 years 5 years 10 years Since Inception
5.4 9.2 17.1 25.7 17.6 9.9 9.4 5.9 Fund

Distribution ($)/unit

YTD* 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Total distributions 0.01 0.34 0.29 0.25 0.53 --- 0.11 0.15 0.13 0.06 0.12
Interest --- 0.00 0.00 0.00 0.00 --- 0.05 0.00 0.00 --- ---
Canadian dividends --- --- --- --- --- --- --- --- --- --- ---
Foreign dividends --- 0.39 0.34 0.29 0.56 --- 0.07 0.18 0.17 0.08 0.15
Foreign taxes paid --- -0.06 -0.05 -0.04 -0.03 --- -0.02 -0.03 -0.04 -0.02 -0.03
Capital gains --- --- --- --- --- --- --- --- --- --- ---
Return of capital --- --- --- --- --- --- --- --- --- --- ---

* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.